Tag: moral panics

Trump Says He’s ‘Ready’ To Impose Death Penalty On People Who Sell Illicit Drugs, Calling Policy ‘Very Humane’

President Donald Trump is again promoting his support for executing people who sell currently illicit drugs, calling it a “very humane” policy to prevent overdose deaths that he’s “ready” to implement.

He also ambitiously projected that his administration will cut drug use in the U.S. by 50 percent during his new term by launching an aggressive advertising campaign to warn Americans about the harms of substance misuse.

During a White House event with governors from across the U.S. on Friday, South Carolina Gov. Henry McMaster (R) told Trump about his concerns with fentanyl trafficking, to which the president responded by offering his extreme capital punishment proposal of following the lead of countries like China that impose the death penalty on people involved in selling illegal drugs.

While he said he’s unsure whether the U.S. as a whole is similarly “ready” to move forward with the policy, Trump encouraged governors to push for it at the state-level.

“If you notice that every country that has the death penalty has no drug problem. They execute drug dealers,” Trump said. “And when you think about it, it’s very humane, because every drug dealer, on average they say, kills at least 500 people—not to mention the damage they do so many others. But they kill large numbers of people.”

Keep reading

RFK Jr. Says Marijuana Can Have ‘Catastrophic Impacts’ On Consumers, But State-Level Legalization Can Spur Research On Its Harms And Benefits

Fresh off his Senate confirmation vote to become the secretary of the U.S. Department of Health and Human Services, Robert F. Kennedy Jr. said on Thursday that he is “worried about” the normalization of high-potency marijuana and that he feels its use can have “really catastrophic impacts” on people, but that state-level legalization can facilitate research into its harms and benefits.

Kennedy, who was vocal about his support for marijuana legalization when he was running for president—as well as during his time on the Trump transition team—has been notably silent on cannabis policy issues over recent months as he worked to win over senators to secure confirmation for the country’s top health role.

Now, during his first major media interview since receiving that final vote to secure the cabinet position earlier in the day, Kennedy told Fox News’s Laura Ingraham that he believes cannabis does hold serious harm potential.

The HHS secretary, who personally struggled with drug addiction during his youth, was asked about his cannabis policy position and noted that he’s been in recovery for over 40 years and attends daily 12-step meetings.

“I hear stories all the time of the impacts of marijuana on people—and the really catastrophic impacts on them,” he said.

However, Kennedy said “that worry also has to be balanced [with] the impacts that we’ve had before” as it relates to criminalization.

“Twenty-five states [have] now legalized marijuana, but we had about a third of our prison population that was in jail because of marijuana offenses,” he said. “That’s something we don’t want either.”

“Because of the legalization of recreational marijuana in 25 states, we have now a capacity to really study it and to compare it to states,” he said. “We need to do studies. We need to figure it out, and then we need to we need to implement policies to address” any health concerns.

Of course, HHS has already completed a comprehensive scientific study into cannabis that led the agency under the Biden administration to recommend moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA).

The new comments come on the same day that Sen. Pete Ricketts (R-NE) said he received a commitment from Kennedy to “follow the science on the harms of marijuana.”

Ricketts had already disclosed last week that he spoke to Kennedy about the the “importance” of “preventing the expansion of marijuana.” Now he says “RFK committed to me that he would follow the science on the harms of marijuana.”

Keep reading

GOP Florida Lawmaker Wonders If State’s Medical Marijuana Program Is ‘Causing More Harm Than Good’

With nearly 900,000 registered patients, Florida has the largest medical marijuana program in the country. While campaigning against a proposed constitutional amendment that would have legalized recreational cannabis last year, Gov. Ron DeSantis (R) hailed the medical program, boasting that he had legalized smokeable weed in the state in 2019.

But that doesn’t mean the Florida GOP-controlled legislature is all in with medical marijuana, and on Tuesday one House member asked a state doctor charged with analyzing the effectiveness of cannabis as medicine if its use by Floridians poses more of a risk than a benefit.

“You’ve made it very clear that there needs to be more research across the gamut of this area, but you’ve also made it clear that a lot of the research that you do have shows this program to be of questionable medical value,” said Northeast Florida Republican Dean Black to Dr. Almut Winterstein, a professor in the College of Pharmacy at the University of Florida and director of the Consortium for Medical Marijuana Outcomes Research.

“My question is, do you fear that we’re causing more harm than good?”

Winterstein replied that the question illuminated the “conundrum” that exists when it comes to the medical efficacy of cannabis, which because it is listed as a Schedule I controlled substance by the federal government has always had restrictions placed on research. (The Biden administration proposed last year to reclassify the substance as a Schedule III controlled substance).

“That is concerning,” she said in response to Black’s query. “That doesn’t mean that there are not patients who might massively benefit from this, but we haven’t defined the benefit of this.”

In her presentation to the House Professions & Programs Subcommittee, Winterstein reported rapid growth among young adults up to age 25 in Florida in listing anxiety as the medical condition motivating them to seek a medical marijuana prescription. She said that was “fairly strong evidence that marijuana attacks the developing brain negatively—specifically, cognitively.”

But she said that was very different than looking at patients suffering from chronic pain or other medical conditions. 

Keep reading

GOP Congressman Wants To Talk With RFK Jr. About How ‘Marijuana Is Harmful’ As Trump’s Cabinet Pick Heads To Confirmation Vote

A GOP congressman says it’s “definitely” time to have a talk with President Donald Trump’s pick for head of the U.S. Department of Health and Human Services (HHS) to convince him that “marijuana is harmful” and that the way to make Americans healthy is by “limiting” its use.

After Robert F. Kennedy Jr. was cleared in an initial confirmation vote in the Senate Finance Committee, Rep. Andy Harris (R-MD) told Marijuana Moment that he wanted to have a chat with the potential HHS secretary, who has previously voiced support for cannabis legalization prior to being selected for the top federal health role by Trump.

“Marijuana is harmful,” Harris said in an interview at the Capitol on Wednesday. “We should definitely have a talk with RFK Jr. I mean, the bottom line is: We should keep Americans healthy by limiting the use of marijuana.”

But Harris—a staunchly anti-cannabis lawmaker who has championed legislation to block adult-use marijuana sales in Washington, D.C.—expressed a softer tone when asked about the therapeutic potential of psychedelics, which is another issue that Kennedy has pushed.

The congressman said it “might be possible” that psychedelics could be used in the treatment of conditions such as post-traumatic stress disorder (PTSD).

“We may want to do some more research, but we don’t want to do what D.C. did, which is just make them widely available,” he said, referencing a voter-approved initiative to decriminalize certain psychedelics—which would not inherently increase availability given the lack of any regulated sales component of the reform.

Meanwhile, despite Harris’s apparent concerns about Kennedy’s history of advocating for cannabis legalization, the nominee said last week that he will defer to the Drug Enforcement Administration (DEA) on marijuana rescheduling if confirmed.

That could complicate rescheduling given the fact that the current acting administrator of DEA, Derek Maltz, has made multiple comments expressing hostility to cannabis reform.

Relatedly, prior to Kennedy’s written responses to the Finance Committee, Sen. Elizabeth Warren (D-MA) recently pressed Kennedy to reiterate his position on marijuana legalization amid the ongoing effort to federally reschedule cannabis.

Keep reading

Analysis: Steep Declines in Teen Marijuana Use in States With Regulated Cannabis Markets

Marijuana use by teens has fallen sharply in the majority of states that have legalized the adult-use market, according to an analysis of state and federal survey data by the Marijuana Policy Project.

MPP’s analysis acknowledges steady declines in self-reported marijuana use by young people in 19 of 21 states for which data is available. Federally funded survey data shows similar nationwide declines in teen marijuana use over the past decade.

“Over a decade into state-level cannabis legalization, the data is unequivocal: Legalization does not increase youth cannabis use. In fact, evidence suggests the opposite,” said Karen O’Keefe, Director of State Policies at the Marijuana Policy Project. “By transitioning cannabis sales from the illicit market to a regulated system with age-restricted access, we’ve seen a decrease in youth cannabis use.”

Last month, national data provided by the University of Michigan’s Monitoring the Future study reported that marijuana use by teens fell to historic lows in 2024. Specifically, it determined that the percentage of 8th graders, 10th graders, and 12 graders who reported having ever consumed cannabis declined 32 percent, 37 percent, and 23 percent since 2014.

Keep reading

Trump’s New DEA Head Says Marijuana Is A ‘Gateway Drug’ That Causes Psychosis And Other Mental Health Problems

The official named to run the Drug Enforcement Administration (DEA) as acting administrator subscribes to the “gateway drug” theory for marijuana and believes most people living in states that have legalized cannabis will continue to obtain it from illicit sources such as cartels due to high taxes in regulated markets.

As the Trump administration takes shape, marijuana reform advocates and stakeholders are getting to learn more about the newly announced acting administrator, Derek Maltz. And so far, a review of his record has done little to assure the cannabis community that he would serve as an ally in the push for reform at DEA.

Maltz, who retired from the agency in 2014 after 28 years of service, has made a series of sensational comments about cannabis—at one point linking marijuana use to school shootings, for example. But he evidently also holds a more common prohibitionist position: He thinks cannabis is a gateway to harder drugs, despite numerous studies contradicting that theory.

“Marijuana is not the marijuana from the 70s or the 80s or the 90s. This is higher, pure-THC marijuana,” he said during an interview with NTD at a Turning Point USA event last year. “I’ve talked to doctors about this. It’s actually causing psychosis, schizophrenia, depression, anxiety—so it’s really a gateway drug for these kids that don’t know any better.”

Keep reading

Trump’s New DEA Head Blamed Marijuana For School Shootings And Claimed Rescheduling Push Was Politically Motivated

The Drug Enforcement Administration (DEA) has a new interim leader—and he’s no fan of marijuana, previously linking cannabis use to school shootings and repeatedly insisting that the Biden administration”hijacked” the rescheduling process from the agency for political purposes.

DEA announced on Monday that Derek Maltz, who retired from the agency in 2014 after 28 years of service, will be serving as acting administrator. With President Donald Trump still having yet to name his choice to run DEA as administrator, it’s unclear if Maltz is positioned to receive that nomination or if he will ultimately be replaced.

But for cannabis advocates and stakeholders, Maltz’s return to DEA for now—especially as anxieties around the fate of the ongoing marijuana rescheduling process grow—represents a troubling development.

Keep reading

Trump’s Choice For Top Justice Department Role Says Marijuana Is A ‘Gateway Drug’ That Makes Consumers ‘Boring And Smelly’

President-elect Donald Trump has made his selection for another top Justice Department official: Harmeet Dhillon, who has peddled the gateway drug theory about marijuana and says cannabis makes people who consume it “silly, boring and smelly.”

Trump said on Monday that he intends to nominate Dhillon as assistant attorney general for civil rights. The lawyer has served in leadership roles with the Republican National Committee and California Republican Party, and she’s a frequent Fox News contributor.

For those following the marijuana policy positions of Trump’s cabinet picks, Dhillon’s comments on the issue reveal a staunch opposition to the use of cannabis, which she claimed is a “gateway drug and ambition-killer” following President Joe Biden’s mass marijuana pardons.

This choice for a key DOJ position also comes amid the final steps of the Biden administration’s efforts to reschedule marijuana—a task that the incoming Trump administration will inherit and which his Justice Department will play a pivotal role in facilitating.

Dhillon doesn’t seem expressly opposed to the idea of preventing people from going to jail over simple cannabis possession, however, and she’s pointed out that federal prosecutors rarely go after people over that low-level offense. At one point, she criticized Vice President Kamala Harris over her prosecutorial record on cannabis.

But she’s made her distaste for cannabis consumption clear on a number of occasions.

Keep reading

Florida Sen. Rick Scott says he’ll vote against recreational pot after brother’s death

Republican Sen. Rick Scott of Florida says he’ll be voting in November against a ballot amendment to legalize recreational marijuana in his state, a deeply personal decision based on his brother’s long history of addiction.

The senator and former Florida governor said he watched his brother Roger Scott begin smoking marijuana as a teenager and then struggle with substance use for the rest of life.

“People end up with addictive personalities, and so he did,” Scott said in an interview. “It messes up your life, and so that’s why I’ve never supported legalization of drugs.”

When Roger Scott died in April at 67, the cause wasn’t substance abuse, but rather “a life of drugs and alcohol” catching up with him, the senator said. He had lived in an apartment in Dallas, Texas, where he served jail time in 1990 on a misdemeanor conviction of possessing dangerous drugs, court records show.

Rick Scott became wealthy as a lawyer and health care industry executive before entering politics. Now running for reelection, he lamented that his brother had a “tough life” and says it all began with marijuana.

Keep reading

We Were Wrong To Panic About Secondhand Smoke

In 2003, UCLA epidemiologist James Enstrom and I published a study of environmental tobacco smoke (ETS)—also called “secondhand smoke” or “passive smoking”—in the British Medical Journal (BMJ). Using data from the American Cancer Society’s prospective study of 1 million adults, we concluded that ETS exposure was not associated with increased mortality.

Since that conclusion flew in the face of the conventional wisdom that had long driven state and local bans on smoking in public places, our study understandably sparked a controversy in the public health community. But the intensity of the attack on us in the pages of a medical journal—by critics who were certain that our study had to be wrong but typically failed to provide specific evidence of fatal errors—vividly illustrates what can happen when policy preferences that have taken on the status of doctrine override rational scientific debate.

A recent study by American Cancer Society (ACS) researchers underscores that point by showing that, contrary to what our critics asserted, the cancer risk posed by ETS is likely negligible. The authors present that striking result without remarking on it, which may reflect their reluctance to revisit a debate that anti-smoking activists and public health officials wrongly view as long settled.

Exposure to ETS is known to cause eye and throat irritation and to exacerbate preexisting respiratory conditions. In addition, it is simply disagreeable to many people (including me). But assessing the claim that ETS is potentially deadly requires dispassionate examination of the available scientific evidence.

That is not what Enstrom and I encountered when we published our BMJ paper. Critics were outraged by the article and demanded its retraction. But they were never able to satisfactorily explain why such an extreme step was justified.

Keep reading